alexa Drug Resistance|Omicsgroup|Journal Of Biotechnology And Biomaterials

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Drug Resistance

For several decades, the phenomenon of drug resistance has remained the greatest challenge to malaria control, and it is part of the obstacles that sapped the dream of seeing malaria eradicated in the years 1970s. So far, resistance has been fully established in three of the five Plasmodium species responsible for human malaria (P. falciparum, P vivax and P. malariae). Cross resistance on the other hand is the simultaneous occurrence of resistance of the same parasite strain to two of more drugs belonging to the same drug family or exerting similar modes of action. Treatment failure is defined as “an inability to clear malarial parasitaemia or resolve clinical symptoms despite administration of an antimalarial medicine”. OMICS Group International is one of the leading Open Access Publishers which is publishing 350 scholarly open access journals with the support of 30,000 well-versed scholars as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 100 international scientific conferences and events yearly all over the world with the support of 100+ scientific associations worldwide.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords